Blackstone Inc
TARA icon

Blackstone Inc’s Protara Therapeutics TARA Stock Holding History

Blackstone Inc’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.8M Buy
2,265,514
+355,852
+19% +$2.11M 0.05% 74
2025
Q4 		$10.2M Hold
1,909,662
– – 0.04% 95
2025
Q3 		$8.31M Hold
1,909,662
– – 0.03% 99
2025
Q2 		$5.79M Buy
1,909,662
+165,620
+9% +$571K 0.02% 99
2025
Q1 		$7.43M Buy
1,744,042
+64,042
+4% +$286K 0.03% 86
2024
Q4 		$8.87M Buy
+1,680,000
New +$5.43M 0.04% 77

Other funds holding TARA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Blackstone Inc's TARA Position: Q1 2026 in Review

Blackstone Inc increased its Protara Therapeutics (TARA) stake by 19% in Q1 2026, buying an estimated $2.11M and bringing the position to 2,265,514 shares worth $11.8M. The position accounts for 0.05% of the portfolio, ranked #74.

Blackstone Inc first reported a position in TARA in Q4 2024 and has held it in 6 quarters since. 114 funds tracked by Wall St. Rank hold TARA as of Q1 2026.

  • Blackstone Inc held 2,265,514 shares of Protara Therapeutics worth $11.8M as of Q1 2026.
  • Blackstone Inc bought 355,852 Protara Therapeutics shares in Q1 2026, an estimated $2.11M.
  • Protara Therapeutics made up 0.05% of Blackstone Inc's portfolio in Q1 2026, its #74 holding.
  • Blackstone Inc first reported a position in Protara Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • 114 funds tracked by Wall St. Rank held Protara Therapeutics as of Q1 2026.

Based on Blackstone Inc's 13F filing for Q1 2026, filed 15 May 2026.